Safety results established in one of the largest prevention studies in HAE

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

The most common side effects of TAKHZYRO are:

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist.

The 6.5-month clinical study

Most common side effects in the 6.5-month clinical study
TAKHZYRO
(84 people)*
Placebo
(41 people)

Injection site reactions

  • Pain
  • Redness
  • Bruising

52%

43%

10%

7%

34%

29%

2%

0%

Upper respiratory infection
29%
32%
Headache
21%
22%
Rash
7%
5%
Muscle pain
5%
0%
Dizziness
6%
0%
Diarrhea
5%
5%
*Included all people treated with TAKHZYRO (300 mg every 2 weeks, 300 mg every 4 weeks, or 150 mg every 4 weeks) in the first study.
Style
section-no-top-margin, section-no-bottom-margin, section-no-top-padding, section-no-bottom-padding
id
clinical-study

The 2.5-year open-label extension study

The most common side effects seen in the long-term, open-label study were injection site reactions (including pain, redness, and bruising), upper respiratory infections, and headache.

Most common side effects in the 2.5-year, long-term, open-label study
TAKHZYRO 300 mg every 2 weeks (212 people)
Injection site pain
47%
Viral upper respiratory tract infection
42%
Upper respiratory tract infection
26%
Headache
25%
Injection site redness
17%
Joint pain
13%
Injection site bruising
12%
Back pain
12%
Diarrhea
11%
Sinus infection
11%
Influenza
10%
Nausea
10%
Urinary tract infection
10%
All side effects in both studies occurred in ≥10% of people taking TAKHZYRO.
Style
section-no-top-margin, section-no-bottom-margin, section-no-top-padding, section-no-bottom-padding
id
ole-study